Predictive models to estimate utility from clinical questionnaires in schizophrenia: findings from EuroSC.

Objective: The clinical symptoms of schizophrenia are associated with serious social, quality of life and functioning alterations. Typically, data on health utilities are not available in clinical studies in schizophrenia. This makes the economic evaluation of schizophrenia treatments challenging. T...

Descripción completa

Detalles Bibliográficos
Publicado en:Quality of Life Research Vol. 25; no. 4; pp. 925 - 935
Autores principales: Siani, Carole, Peretti, Christian, Millier, Aurélie, Boyer, Laurent, Toumi, Mondher, de Peretti, Christian
Formato: research Journal Article
Publicado: Springer Nature Apr2016
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=114514208&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 114514208
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        09629343
        GPQ
      jtl: Quality of Life Research
      issn: 09629343
      maglogo: N
    pubinfo:
      dt: Apr2016
      vid: 25
      iid: 4
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        114514208
        114514208
        NLM26385367
        114514208
        10.1007/s11136-015-1120-6
        NLM26385367
        PMC4830865
        114514208
      ppf: 925
      ppct: 10
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Predictive models to estimate utility from clinical questionnaires in schizophrenia: findings from EuroSC.
      aug:
        au:
          Siani, Carole
          Peretti, Christian
          Millier, Aurélie
          Boyer, Laurent
          Toumi, Mondher
          de Peretti, Christian
          Millier, Aurélie
        affil: Research Laboratory in Knowledge Engineering (ERIC, EA3083), Institute of Pharmaceutical and Biological Sciences (ISPB), University Claude Bernard Lyon 1, 11 Rue Guillaume Paradin 69372 Lyon Cedex 08 France
      sug:
        subj:
          Models, Theoretical
          Depression Diagnosis
          Quality of Life Psychosocial Factors
          Antipsychotic Agents Therapeutic Use
          Schizophrenia Drug Therapy
          Human
          Adult
          Male
          Prospective Studies
          Adolescence
          Middle Age
          Female
          Young Adult
          France
          Linear Regression
          Germany
          Treatment Outcomes
          Aged
          Validation Studies
          Comparative Studies
          Evaluation Research
          Multicenter Studies
          Scales
          Questionnaires
          Adult: 19-44 years
          Adolescent: 13-18 years
          Middle Aged: 45-64 years
          Aged: 65+ years
          Male
          Female
      ab: Objective: The clinical symptoms of schizophrenia are associated with serious social, quality of life and functioning alterations. Typically, data on health utilities are not available in clinical studies in schizophrenia. This makes the economic evaluation of schizophrenia treatments challenging. The purpose of this article was to provide a mapping function to predict unobserved utility values in patients with schizophrenia from the available clinical and socio-demographic information.Methods: The analysis was performed using data from EuroSC, a 2-year, multi-centre, cohort study conducted in France (N = 288), Germany (N = 618), and the UK (N = 302), totalling 1208 patients. Utility was calculated based on the EQ-5D questionnaire. The relationships between the utility values and the patients' socio-demographic and clinical characteristics (Positive and Negative Syndrome Scale--PANSS, Calgary Depression Scale for Schizophrenia--CDSS, Global Assessment of Functioning--GAF, extra-pyramidal symptoms measured by Barnes Akathisia Scale-BAS, age, sex, country, antipsychotic type) were modelled using a random and a fixed individual effects panel linear model.Results: The analysis demonstrated the prediction ability of the used parameters for estimating utility measures in patients with schizophrenia. Although there are small variations between countries, the same variables appear to be the key predictors. From a clinical perspective, age, gender, psychopathology, and depression were the most important predictors associated with the EQ-5D.Conclusion: This paper proposed a reliable, robust and easy-to-apply mapping method to estimate EQ-5D utilities based on demographic and clinical measures in schizophrenia.
      pubtype: Academic Journal
      doctype:
        research
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N